- Home
- NGS vs MRVI Comparison
NGS vs MRVI Comparison
Compare NGS & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGS
- MRVI
- Stock Information
- Founded
- NGS 1998
- MRVI 2014
- Country
- NGS United States
- MRVI United States
- Employees
- NGS N/A
- MRVI N/A
- Industry
- NGS Oilfield Services/Equipment
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- NGS Energy
- MRVI Health Care
- Exchange
- NGS Nasdaq
- MRVI Nasdaq
- Market Cap
- NGS 312.1M
- MRVI 312.4M
- IPO Year
- NGS 2002
- MRVI 2020
- Fundamental
- Price
- NGS $26.92
- MRVI $2.08
- Analyst Decision
- NGS Strong Buy
- MRVI Hold
- Analyst Count
- NGS 2
- MRVI 10
- Target Price
- NGS $32.50
- MRVI $6.84
- AVG Volume (30 Days)
- NGS 74.9K
- MRVI 1.5M
- Earning Date
- NGS 08-13-2025
- MRVI 08-06-2025
- Dividend Yield
- NGS N/A
- MRVI N/A
- EPS Growth
- NGS 76.16
- MRVI N/A
- EPS
- NGS 1.34
- MRVI N/A
- Revenue
- NGS $161,218,000.00
- MRVI $241,856,000.00
- Revenue This Year
- NGS $13.56
- MRVI N/A
- Revenue Next Year
- NGS $15.42
- MRVI $10.73
- P/E Ratio
- NGS $20.25
- MRVI N/A
- Revenue Growth
- NGS 22.64
- MRVI N/A
- 52 Week Low
- NGS $16.70
- MRVI $1.67
- 52 Week High
- NGS $29.74
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- NGS 69.77
- MRVI 46.40
- Support Level
- NGS $24.75
- MRVI $2.00
- Resistance Level
- NGS $27.59
- MRVI $2.44
- Average True Range (ATR)
- NGS 0.85
- MRVI 0.15
- MACD
- NGS 0.10
- MRVI -0.03
- Stochastic Oscillator
- NGS 81.69
- MRVI 20.45
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.